DISSEMINATED BLASTOMYCOSIS

This adverse event was reported 171 times

DISSEMINATED BLASTOMYCOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ERAVACYCLINE 2 0.0067
1 BELATACEPT 9 0.0019
2 AMPHOTERICIN B 18 0.0014
3 ACETAZOLAMIDE SODIUM 7 0.0011
4 ITRACONAZOLE 13 0.0011
5 BASILIXIMAB 12 0.0010
6 MYCOPHENOLATE MOFETIL 93 0.0007
7 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 93 0.0007
8 TACROLIMUS OINTMENT 0.1% 79 0.0006
9 TACROLIMUS EXTENDED-RELEASE CAPSULES 79 0.0006
See all drugs enriched for association with DISSEMINATED BLASTOMYCOSIS